Sales and Marketing

Showing 15 posts of 11527 posts found.

Demand for hydroxychloroquine soars after Trump says it can treat coronavirus

March 25, 2020 Research and Development, Sales and Marketing COVID-19, Wuhan Coronavirus, china coronavirus, coronavirus, covid19

President Trump has continually touted the effectiveness of anti-malaria drug Hydroxychloroquine in treating coronavirus which has led to a jump …

AstraZeneca to leverage Silence Therapeutics’ siRNA expertise in $480mn deal

March 25, 2020 Research and Development, Sales and Marketing AstraZeneca, Silence Therapeutics, collaboration, pharma

Silence Therapeutics has revealed it has struck a new collaboration with AstraZeneca which will trigger the “acceleration and re-prioritisation of …

Sustainability and security: How packaging is modernising pharma

March 24, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing counterfeit medicines, falsified medicines, feature, packaging, pharma

In a world living in the shadow of substandard and falsified medicines, climate change and antimicrobial resistance, pharmaceutical packaging will …

FDA turns down label expansion for Jardiance as an adjunct to insulin in type 1 diabetes

March 23, 2020 Sales and Marketing FDA, diabetes, jardiance, pharma

The FDA has chosen not to approve an expanded indication of 2.5mg Jardiance (empaglifozin) as an adjunct to insulin in …

More young coronavirus patients being hospitalised in Europe and US compared to China

March 23, 2020 Sales and Marketing COVID-19, Wuhan Coronavirus, china coronavirus, coronavirus

Dr Anthony Fauci, the Director of the National Institute of Allergy and Infectious Disease in the US, said that people …

ViiV Healthcare scores world-first approval in Canada for monthly HIV regimen Cabenuva

March 23, 2020 Sales and Marketing Cabenuva, Canada, HIV, pharma

ViiV Healthcare has secured its first global approval for its once-monthly treatment Cabenuva, it has emerged, to replace current antiretroviral …

AI may help predict patient response to non-small cell lung cancer therapies

March 23, 2020 Medical Communications, Sales and Marketing Cancer, Lesions, cancer treatment, tumour treatment

Researchers have used artificial intelligence to train algorithms to predict tumour sensitivity to systemic cancer therapies. Radiologists previously determined if …

US continues sanctions against Iran despite coronavirus ravaging both nations

March 23, 2020 Manufacturing and Production, Sales and Marketing Iran, Iran US, US, coronavirus

The Trump administration is not relaxing sanctions on Iran, despite the country having one of the highest death tolls from …

Top Ten most popular articles on Pharmafile.com this week

March 20, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Chinese Coronavirus, Wuhan Coronavirus, china coronavirus, coronavirus

The COVID-19 coronavirus continues to dominate the news: A flu drug has appeared to be effective in treating COVID-19 while …

Drug launches across Europe will be affected by coronavirus

March 20, 2020 Medical Communications, Sales and Marketing EU, Europe, coronavirus, pharma

The COVID-19 pandemic will affect European launches of drugs for a host of diseases including HIV, cancer and sickle cell …

Japan grants orphan drug designation to Lynparza for BRCA+ unresectable pancreatic cancer

March 19, 2020 Research and Development, Sales and Marketing AstraZeneca, Japan, lynparza, pharma

AstraZeneca has confirmed that its PARP inhibitor Lynparza (olaparib) has been awarded orphan drug designation in Japan for the maintenance …

Japan approves Novartis’ Zolgensma for spinal muscular atrophy in patients under two years old

March 19, 2020 Sales and Marketing Japan, Novartis, Zolgensma, pharma, spinal muscular atrophy

Novartis has revealed that its gene therapy Zolgensma (onasemnogene abeparvovec) has secured approval from Japan’s Ministry of Health, Labour and …

Global drug spending projected to reach $1.1 trillion by 2024, report argues

March 18, 2020 Research and Development, Sales and Marketing IQVIA, pharma, report

Total global spending on medicines is set to break $1.1 trillion by 2024, a new report released by IQVIA has …

$63bn Allergan/AbbVie merger review could be delayed by coronavirus

March 18, 2020 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AbbVie, Allergan, merger, pharma

The $63 billion merger of major pharma players AbbVie and Allergan could be facing hurdles on the road to regulatory …

NICE promotes Professor Gillian Leng as its new Chief Executive

March 18, 2020 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing NHS, NICE, UK, pharma

NICE, the drug watchdog for the NHS in England and Wales, has announced that it has promoted Professor Gillian Leng …
The Gateway to Local Adoption Series

Latest content